Skip to main content
Equibles

DC Funds, LP

Position in TCRX — TScan Therapeutics, Inc.

CIK 1869028 MCLEAN, VA
Back to TCRX Full portfolio

Position in TCRX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$617,400
-$18,900 QoQ
Shares Held
630,000
0.0% QoQ
Ownership
0.929%
of shares outstanding
% of Portfolio
49.26%
of 13F equity value
Holder Rank
#15
of 60 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TCRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

DC Funds, LP holds $1,253,330 across 3 Biotechnology names. TCRX ranks #1 (49.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TCRX
TScan Therapeutics, Inc.
This page 		630,000 $617,400
2 BRNS
Barinthus Biotherapeutics plc.
 642,204 $423,854
3 HOWL
Werewolf Therapeutics, Inc.
 589,102 $212,076

All Filings in TCRX

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $617,400 630,000
2026-03-31 $636,300 630,000
2025-12-31 $630,000 630,000
2025-09-30 $1,146,600 630,000
2025-06-30 $913,500 630,000
2025-03-31 $869,400 630,000
2024-12-31 $1,915,200 630,000
2024-09-30 $3,137,400 630,000
2024-06-30 $3,685,500 630,000
2024-03-31 $5,002,200 630,000
2023-12-31 $3,672,900 630,000
2023-09-30 $1,612,800 630,000
2023-06-30 $1,575,000 630,000
2023-03-31 $1,323,000 630,000
2022-12-31 $976,500 630,000
2022-09-30 $1,921,500 630,000
2022-06-30 $1,981,350 630,000
2022-03-31 $1,764,000 630,000
2021-12-31 $2,835,000 630,000
2021-09-30 $5,254,200 630,000